A.I.M.S.BIOTEK
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Jan 2022)
What this means for you
This application is over — abandoned 24 Jan 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87916254
- Mark type
- Stylized text
- Filed
- 10 May 2018
- Published for opposition
- 23 Apr 2019
- Abandoned
- 24 Jan 2022
- Attorney of record
- Donna J. Bunton
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; interferons; parenterally administered interferon for use in treating viral diseases and cancer; intranasal solutions for use as a vaccine adjuvant
Owner
- AIM IMMUNOTECH INC., OCALA, FL, US
- HEMISPHERX BIOPHARMA, INC., Orlando, FL, US
- HEMISPHERX BIOPHARMA, INC., Orlando, FL, US
Prosecution history
- 24 Jan 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Jan 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2021 — SOU EXTENSION 4 GRANTED
- 10 Jun 2021 — SOU EXTENSION 4 FILED
- 10 Jun 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2020 — SOU EXTENSION 3 GRANTED
- 30 Nov 2020 — SOU EXTENSION 3 FILED
- 30 Nov 2020 — SOU TEAS EXTENSION RECEIVED
- 20 Jun 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2020 — SOU EXTENSION 2 GRANTED
- 18 Jun 2020 — SOU EXTENSION 2 FILED
- 18 Jun 2020 — SOU TEAS EXTENSION RECEIVED
- 20 Dec 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED